Follistatin 344 Dosage Guide: How Much Should You Take? (2026)
Key Takeaways
- Standard Dosage Range: Follistatin 344 is typically dosed between 100-300 mcg per injection, depending on the administration route and intended use.
- Administration Method: Commonly administered subcutaneously or intramuscularly, with specific protocols for each route.
- Typical Cycle Length: Treatment cycles usually last 4-6 weeks, with breaks recommended to assess efficacy and safety.
- Regulatory Status: Follistatin 344 is not FDA-approved and is available for research purposes only.
- Medical Supervision: Essential for monitoring potential side effects and ensuring safe use.
How Follistatin 344 Works in the Body
Follistatin 344 is a peptide known for its role in muscle differentiation and growth factor regulation. It functions by binding to myostatin and activin-A, inhibiting their activity and modulating TGF-β signaling pathways. This interaction leads to the inhibition of Smad2/3 signaling, which is crucial for muscle growth and repair.
The pharmacokinetics of Follistatin 344, including its receptor binding affinity, half-life, and bioavailability, significantly influence dosing decisions. Research suggests that the peptide's half-life is relatively short, necessitating frequent administration to maintain effective plasma concentrations. A study published in Transgenic Research demonstrated that the transgenic expression of human Follistatin 344 increased skeletal muscle mass in pigs, highlighting its potential for muscle growth applications (PMID: 27787698).
"The transgenic expression of human follistatin-344 increases skeletal muscle mass in pigs." — Transgenic Research (2017)
Additionally, Follistatin 344's bioavailability varies with the administration route, impacting how much of the peptide reaches systemic circulation. Understanding these properties is crucial for determining appropriate dosing regimens and optimizing therapeutic outcomes.
Standard Follistatin 344 Dosage Ranges (By Form)
Subcutaneous Administration
- Dosage Range: 100-300 mcg per injection
- Frequency: Typically administered once daily or every other day
- Bioavailability: Moderate, with direct absorption into the bloodstream
Subcutaneous injection is the most common form of administration due to its ease and effectiveness. The peptide is absorbed directly into the bloodstream, providing a consistent release.
Intramuscular Administration
- Dosage Range: 100-300 mcg per injection
- Frequency: Administered once every 2-3 days
- Bioavailability: Slightly higher than subcutaneous, with a prolonged release
Intramuscular injections offer a slightly higher bioavailability and a more prolonged release compared to subcutaneous administration. This method is preferred for individuals seeking sustained effects.
Oral and Other Forms
Currently, no clinically validated oral or topical forms of Follistatin 344 are available. Research on alternative administration routes is ongoing, but subcutaneous and intramuscular methods remain the standard due to their proven efficacy and bioavailability.
Follistatin 344 Dosage by Use Case
Muscle Growth and Recovery
- Typical Dosage Range: 200-300 mcg per injection
- Administration Method: Subcutaneous or intramuscular
- Cycle Length: 4-6 weeks
Follistatin 344 is primarily used for muscle growth and recovery, capitalizing on its ability to inhibit myostatin. Many clinics prescribe a 4-6 week cycle, with doses adjusted based on individual response and goals.
Anti-Aging and Longevity
- Typical Dosage Range: 100-200 mcg per injection
- Administration Method: Subcutaneous
- Cycle Length: 6-8 weeks
For anti-aging purposes, lower doses are often utilized to leverage Follistatin 344's potential regenerative properties. Longer cycles may be employed, with careful monitoring for efficacy and safety.
Research Applications
- Typical Dosage Range: Variable based on study design
- Administration Method: Subcutaneous or intramuscular
- Cycle Length: Dependent on research protocol
In research settings, dosing can vary widely based on the specific aims of the study. Clinical protocols typically dictate the dosage and administration schedule to achieve desired outcomes.
How Long Should You Take Follistatin 344?
The typical cycle length for Follistatin 344 ranges from 4 to 6 weeks. During the initial weeks, users may begin to notice subtle changes in muscle tone and recovery. By weeks 2-4, more pronounced effects such as increased muscle mass and strength may be observed. After week 6, it is advisable to take a break to assess the peptide's impact and allow the body to reset.
There is limited data on the necessity of tapering off Follistatin 344, but gradual discontinuation may help mitigate any potential withdrawal effects. When stopping the peptide, users should monitor for any changes in muscle mass or recovery and adjust future cycles accordingly.
Administration Protocol: How to Take Follistatin 344
Injection Technique
- Needle Gauge: 25-30 gauge for subcutaneous, 22-25 gauge for intramuscular
- Injection Sites: Rotate between abdomen, thigh, and upper arm for subcutaneous; deltoid or gluteus for intramuscular
- Rotation Schedule: Rotate sites with each injection to minimize tissue irritation
Storage Requirements
- Temperature: Store lyophilized powder at -20°C; reconstituted solution at 2-8°C
- Light Sensitivity: Protect from light to preserve stability
- Reconstituted Stability: Use within 14 days when stored properly
Reconstitution Instructions
For detailed reconstitution instructions, refer to our reconstitution guide.
Step-by-Step Administration Process
- Wash Hands: Ensure hands are clean to prevent contamination.
- Prepare the Injection Site: Clean the area with an alcohol swab.
- Draw the Peptide: Use a sterile syringe to draw the reconstituted peptide.
- Inject: Administer the injection at a 45-degree angle for subcutaneous or 90-degree for intramuscular.
- Dispose Properly: Safely dispose of the syringe and needle.
Stacking Follistatin 344 for Better Results
Common Stacks
-
Follistatin 344 + BPC-157
- Purpose: Enhanced muscle recovery and repair
- Dosing Synergy: Follistatin 344 at 200 mcg, BPC-157 at 250 mcg daily
- Protocol: Often used in post-injury recovery protocols
-
Follistatin 344 + Ipamorelin
- Purpose: Synergistic muscle growth and fat loss
- Dosing Synergy: Follistatin 344 at 200 mcg, Ipamorelin at 100 mcg twice daily
- Protocol: Common in bodybuilding cycles
Named Protocols
- "Wolverine Protocol": A combination of Follistatin 344, BPC-157, and TB-500 for accelerated healing and muscle growth.
Factors That Affect Your Follistatin 344 Dosage
Several factors can influence the appropriate dosage of Follistatin 344:
- Body Weight: Heavier individuals may require higher doses to achieve desired effects.
- Age: Older individuals may respond differently, necessitating dose adjustments.
- Treatment Goals: Specific objectives, such as muscle growth or anti-aging, will dictate dosing.
- Kidney/Liver Function: Impaired function may require dose modifications to prevent accumulation.
- Other Medications: Concurrent medications can interact with peptide therapy, affecting efficacy and safety.
Healthcare providers tailor dosing based on these factors to ensure optimal outcomes and minimize risks.
Common Dosing Mistakes to Avoid
- Dosing Too High/Too Low: Adjust doses based on clinical guidance and individual response.
- Inconsistent Timing: Maintain a consistent schedule to ensure stable plasma levels.
- Wrong Injection Site for the Goal: Use appropriate sites for subcutaneous vs. intramuscular injections.
- Not Accounting for Regulatory Status: Remember that Follistatin 344 is for research use only.
- Poor Storage/Handling: Follow storage guidelines to preserve peptide stability and efficacy.
What the Evidence Does Not Show
While Follistatin 344 shows promise in preclinical studies, there are notable limitations:
- Long-Term Safety Data: Limited human trials mean long-term safety remains unclear.
- Lack of Human Trials: Most data come from animal studies or anecdotal reports.
- Dose-Response Data Limitations: More research is needed to establish precise dose-response relationships.
FAQ — Your Top Follistatin 344 Dosage Questions Answered
What is the best time of day to take Follistatin 344?
There is no specific best time, but consistent timing each day is recommended.
What if you miss a dose?
If you miss a dose, take it as soon as you remember unless it's close to the next dose. Do not double up.
Can men and women use the same dose?
Dosing may vary based on individual factors rather than gender alone.
Can you stack it with other peptides?
Yes, Follistatin 344 is often stacked with peptides like BPC-157 for enhanced effects.
How long until you see results?
Results may begin to appear after 2-4 weeks, depending on individual response and goals.
Do you need to cycle off?
Cycling off after 4-6 weeks is recommended to assess effects and reduce potential risks.
Is a loading dose needed?
A loading dose is not typically required for Follistatin 344.
How to adjust dose if side effects occur?
Consult your healthcare provider to adjust the dose or discontinue use if side effects are experienced.
Conclusion — Finding the Right Dosage for You
Determining the right dosage of Follistatin 344 involves considering individual factors and therapeutic goals. While standard dosing ranges provide a starting point, medical supervision is crucial for tailoring treatment to your needs. For more information on peptide therapy and to find a qualified provider, use our clinic finder and explore related content on Follistatin 344.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Dosage information is compiled from published research and clinical protocols. Consult a licensed healthcare provider before starting any peptide therapy. Use our clinic finder to locate a qualified provider near you.
Find a Peptide Therapy Clinic Near You
Browse our directory of verified peptide therapy clinics across the United States. Compare providers, read reviews, and request a consultation.
PeptideClinicLocator.com does not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy. Regulatory status may change.



